儿童变应性鼻炎鼻用糖皮质激素规范使用专家共识  

Expert consensus on the standardized use of intranasal corticosteroids in children with allergic rhinitis

作　　者：福棠儿童医学发展研究中心药学专业委员会 福棠儿童医学发展研究中心耳鼻咽喉头颈外科专业委员会 北京医学会临床药学分会 王晓玲[2] 张杰[2] 刘小会[2] 王妍[3] Pharmacy Professional Committee,Futang Research Center of Pediatric Development;Pediatric Otorhinolaryngology Head and Neck Surgery Professional Committee,Futang Research Center of Pediatric Development;Clinical Pharmacology Society,Beijing Medical Association;Wang Xiaoling;Zhang Jie

机构地区：[1]不详 [2]国家儿童医学中心,首都医科大学附属北京儿童医院 [3]天津市儿童医院

出　　处：《中华实用儿科临床杂志》2023年第11期814-820,共7页Chinese Journal of Applied Clinical Pediatrics

摘　　要：儿童变应性鼻炎(allergic rhinitis,AR)作为常见的慢性炎症性疾病,对患儿的身心健康均造成显著不良影响,并且增加罹患其他变应性疾病的风险。鼻用糖皮质激素(简称鼻用激素)作为目前治疗AR最有效的药物,在临床中存在使用不规范现象。为此,福棠儿童医学发展研究中心药学专业委员会、福棠儿童医学发展研究中心耳鼻咽喉头颈外科专业委员会和北京医学会临床药学分会组织相关专家以儿童鼻用激素临床常见使用问题为导向,参考国内外最新循证医学研究结果,经多学科药学和临床专家讨论达成共识,以期为临床规范使用鼻用激素提供帮助。Allergic rhinitis(AR)in children,as a common chronic inflammatory disease,has significant adverse effects on the physical and mental health,and increases the risk of developing other allergic diseases.Intranasal corticosteroids(INCS),as the most effective drug for treating AR,still have misunderstandings in clinical standardized use.Therefore,Pharmacy Professional Committee,Futang Research Center of Pediatric Development,Pediatric Otorhinolaryngology Head and Neck Surgery Professional Committee,Futang Research Center of Pediatric Development and Clinical Pharmacology Society,Beijing Medical Association organized relevant experts to guide the common clinical usage issues of pediatric INCS,referring to the latest evidence-based medicine research results at home and abroad,and reaching a consensus through discussions among multidisciplinary pharmaceutical and clinical experts,with the aim of providing help for the standardized use of INCS in clinical practice.

关 键 词：变应性鼻炎 鼻用糖皮质激素 儿童 规范使用 

分 类 号：R765.21[医药卫生—耳鼻咽喉科]